Drug Discovery

How Are Innovations in Medicine and Nanotech Changing Lives?
Tech & Innovation How Are Innovations in Medicine and Nanotech Changing Lives?

Ivan Kairatov is a distinguished figure in the biopharma industry, renowned for his expertise in tech and innovation within the field. With a robust background in research and development, Ivan has substantially influenced advancements in cellular therapies and drug development. Today, we delve

FDA Grants Fast Track to Verve's VERVE-102 for Heart Disease
Research & Development FDA Grants Fast Track to Verve's VERVE-102 for Heart Disease

Verve Therapeutics has announced a significant advancement in genetic medicine as their investigational drug VERVE-102 receives Fast Track designation from the U.S. Food and Drug Administration (FDA). This approval marks a crucial step in the development of treatments for hyperlipidemia and

Shingles Vaccine Linked to 20% Lower Dementia Risk in Seniors
Tech & Innovation Shingles Vaccine Linked to 20% Lower Dementia Risk in Seniors

A research study published in Nature has revealed a groundbreaking link between the shingles vaccine and a significant reduction in the risk of developing dementia among seniors. By leveraging data from the 2013 implementation of a shingles immunization program in Wales, researchers have identified

Novartis' Vanrafia Approved by FDA for Rare Kidney Disease Treatment
Management & Regulatory Novartis' Vanrafia Approved by FDA for Rare Kidney Disease Treatment

Ivan Kairatov is a recognized authority in the biopharma sector, with an extensive background in technological advancements and R&D. In this interview, Ivan shares his insights on the new FDA-approved treatment for IgA nephropathy (IgAN), shedding light on its significance in treating this rare

Imipridones and Standard Treatment Show Promise for Glioblastoma
Research & Development Imipridones and Standard Treatment Show Promise for Glioblastoma

Glioblastoma, one of the most aggressive and treatment-resistant forms of brain cancer, presents a dire prognosis even with current standard treatment regimens including surgery, radiation, and the chemotherapy drug temozolomide (TMZ). However, a groundbreaking study published in Volume 16 of

How Is AI Revolutionizing Precision Medicine by 2029?
Management & Regulatory How Is AI Revolutionizing Precision Medicine by 2029?

The dramatic rise in the global AI in precision medicine market projects an impressive 25-30% surge by 2029. This rapid growth stems from numerous factors: breakthroughs in AI technology, escalating demand for personalized healthcare, the proliferation of genomic data, supportive government

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later